MARRA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 117
EU - Europa 62
AS - Asia 37
Totale 216
Nazione #
US - Stati Uniti d'America 117
IE - Irlanda 43
CN - Cina 23
FI - Finlandia 10
IN - India 4
IR - Iran 4
SG - Singapore 4
CZ - Repubblica Ceca 3
DE - Germania 3
SE - Svezia 2
IT - Italia 1
KG - Kirghizistan 1
MY - Malesia 1
Totale 216
Città #
Dublin 43
Chandler 40
Boardman 11
Helsinki 10
Shanghai 7
Lawrence 6
Medford 6
Princeton 6
Ashburn 5
Nanjing 5
Pune 4
Beijing 3
Brno 3
Wilmington 3
Changsha 2
Dallas 2
Los Angeles 2
Seattle 2
Singapore 2
Bishkek 1
Bologna 1
Fairfield 1
Falkenstein 1
Hebei 1
Jacksonville 1
Jiaxing 1
Jinan 1
Kish 1
Monmouth Junction 1
Nanchang 1
Ningbo 1
Shenyang 1
Totale 175
Nome #
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients. Phase I ZANTE trial 46
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 43
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 35
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 35
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 33
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study * 32
Totale 224
Categoria #
all - tutte 1.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 2 0 1 2 0 0
2020/20214 0 0 0 0 0 0 0 1 3 0 0 0
2021/202229 0 0 1 0 0 0 0 3 4 2 0 19
2022/2023106 14 12 2 5 9 6 0 5 51 1 1 0
2023/202449 7 14 1 0 3 10 3 2 0 2 0 7
2024/202517 5 8 4 0 0 0 0 0 0 0 0 0
Totale 224